Fri, January 24, 2025
Thu, January 23, 2025
Wed, January 22, 2025

Avidity Biosciences CFO sells $93,985 in stock

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. idity-biosciences-cfo-sells-93-985-in-stock.html
  Print publication without navigation Published in Stocks and Investing on by MSN
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
  Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

The article from MSN Money discusses a recent transaction by Avidity Biosciences' Chief Financial Officer (CFO), Michael F. MacLean, who sold shares of the company's stock. On June 12, 2023, MacLean sold 12,512 shares at an average price of $7.51 per share, totaling approximately $93,985. This sale was part of a series of insider transactions at Avidity Biosciences, where insiders have been both buying and selling shares over the past year. The article provides context on insider trading, noting that while such sales can sometimes signal a lack of confidence in the company's future, they can also be for personal financial reasons unrelated to the company's performance. Avidity Biosciences, a clinical-stage biopharmaceutical company, focuses on developing treatments for rare diseases, and its stock performance and insider trading activities are often closely watched by investors for insights into the company's health and prospects.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/topstocks/avidity-biosciences-cfo-sells-93-985-in-stock/ar-AA1xLaPh ]